High-dose trivalent inactivated influenza vaccine safe in elderly

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1816卷 / 1期
关键词：
D O I：
10.1007/s40278-020-81642-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [1] Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥ 65 Years
    Kaka, Anjum S.
    Filice, Gregory A.
    Myllenbeck, Sharon
    Nichol, Kristin L.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [2] Provider knowledge of trivalent inactivated and high-dose influenza vaccines
    Tewell, Chad
    Wright, Patty W.
    Talbot, H. Keipp
    [J]. VACCINE, 2014, 32 (46) : 6025 - 6028
  • [3] Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
    Samson, Sandrine I.
    Leventhal, Phillip S.
    Salamand, Camille
    Meng, Ya
    Seet, Bruce T.
    Landolfi, Victoria
    Greenberg, David
    Hollingsworth, Rosalind
    [J]. EXPERT REVIEW OF VACCINES, 2019, 18 (03) : 295 - 308
  • [4] High-dose trivalent influenza vaccine: safety and immunogenicity
    Ortiz de Lejarazu, Raul
    Martinon Torres, Federico
    Gil de Miguel, Angel
    Diez Domingo, Javier
    Redondo Marguello, Esther
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (01) : 1 - 11
  • [5] Trivalent inactivated influenza vaccine is safe for young children
    不详
    [J]. EXPERT REVIEW OF VACCINES, 2006, 5 (06) : 749 - 749
  • [6] High-dose trivalent influenza vaccine. Efficacy and effectiveness
    Gil de Miguel, Angel
    Redondo Marguello, Esther
    Diez Domingo, Javier
    Ortiz de Lejarazu, Raul
    Martinon Torres, Federico
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (04) : 226 - 239
  • [7] Better outcomes with high-dose trivalent influenza vaccine in seniors
    Machado, Marina A.
    Moura, Cristiano S.
    Abrahamowicz, Michal
    Ward, Brian J.
    Pilote, Louise
    Bernatsky, Sasha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 88 - 89
  • [8] High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults
    Chahine, Elias B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (01) : 89 - 97
  • [9] Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
    Halasa, Natasha B.
    Savani, Bipin N.
    Asokan, Ishan
    Kassim, Adetola
    Simons, Rhea
    Summers, Chelsey
    Bourgeois, John
    Clifton, Carey
    Vaughan, Leigh Ann
    Lucid, Catherine
    Wang, Li
    Fonnesbeck, Christopher
    Jagasia, Madan
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 528 - 535
  • [10] Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age
    DiazGranados, Carlos A.
    Saway, William
    Gouaux, James
    Baron, Mira
    Baker, Jeffrey
    Denis, Martine
    Jordanov, Emilia
    Landolfi, Victoria
    Yau, Eddy
    [J]. VACCINE, 2015, 33 (51) : 7188 - 7193
12345